Fig. 2From: Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching studyProgression-free survival and overall survival. Kaplan-Meier curves for progression-free survival (A) and overall survival (B)Back to article page